{"filings":[{"id":2271998,"accession_number":"0001683168-26-006479","cik":790526,"company_name":"RadNet, Inc.","ticker":"RDNT","form_type":"8-K","filed_at":"2026-08-14T20:17:29+00:00","items":["8.01","9.01"],"status":"ready","headline":"RadNet registers 34,069 shares for resale by See-Mode sellers","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Registers up to 34,069 shares of common stock for resale by See-Mode Sellers.","Shares are milestone consideration under Share Purchase Agreement dated June 2, 2025.","Purchaser is DH AI International Holdings B.V., a wholly-owned RadNet subsidiary.","Prospectus supplement filed Aug 14, 2026; legal opinion by EVP/CLO David J. Katz."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":4233666943.59793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":2143758,"accession_number":"0001683168-26-006125","cik":790526,"company_name":"RadNet, Inc.","ticker":"RDNT","form_type":"8-K","filed_at":"2026-08-10T10:07:05+00:00","items":["2.02","9.01"],"status":"ready","headline":"RadNet Q2 revenue up 25% to $622.7M, raises FY2026 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 revenue $622.7M (+25% YoY); Adjusted EBITDA $99.7M (+22.7%); net income $7.5M vs $14.5M.","Digital Health revenue $32.4M (+56.5%); ARR $105.5M, up 97% YoY; external customers ~63% of DH revenue.","Adjusted EPS $0.29 vs $0.34; GAAP EPS $0.10 vs $0.19; weighted diluted shares 78.7M.","Raises FY2026 Imaging Center guidance: revenue $2.37-2.42B, EBITDA $345-358M, FCF $115-125M.","FDA cleared DeepHealth breast ultrasound AI; JV with Trinity Health Saint Alphonsus in Boise for 5 centers."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":4233666943.59793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":975276,"accession_number":"0001683168-26-004716","cik":790526,"company_name":"RadNet, Inc.","ticker":"RDNT","form_type":"8-K","filed_at":"2026-06-10T21:23:08+00:00","items":["1.01","2.03","7.01","9.01"],"status":"ready","headline":"RadNet secures $250M incremental term loan, reduces credit facility interest rates by 0.25%","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Entered $250M incremental term loan (2026 Incremental Term Loan) added to existing term loan.","Proceeds to finance acquisitions, organic expansion, health system partnerships, general corporate purposes.","Interest rate on term loan reduced by 0.25% to Term SOFR+2.00% or alternate base+1.00%; revolver (undrawn $282M) also reduced.","Maturity April 18, 2031, same as existing $958.7M term loan; quarterly principal payments increased to ~$3.1M from ~$2.4M.","Call protection provided to term loan lenders for six months following the amendment."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":4233666943.59793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":842437,"accession_number":"0001683168-26-004522","cik":790526,"company_name":"RadNet, Inc.","ticker":"RDNT","form_type":"8-K","filed_at":"2026-06-04T01:08:18+00:00","items":["5.07"],"status":"ready","headline":"RadNet shareholders approve all four proposals at 2026 annual meeting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Six directors elected; highest 'For' votes: 64.4M (Sorensen), lowest: 56.9M (Jacobs). Broker non-votes 8.1M each.","Ratification of Ernst & Young passed with 72.9M for (99.3% of votes cast).","Non-binding say-on-pay passed with 61.2M for (94.0% of votes cast).","Amendment of equity incentive plan passed with 63.3M for (97.1% of votes cast)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":4233666943.59793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":815918,"accession_number":"0001683168-26-004475","cik":790526,"company_name":"RadNet, Inc.","ticker":"RDNT","form_type":"8-K","filed_at":"2026-06-03T12:07:02+00:00","items":["8.01","9.01"],"status":"ready","headline":"RadNet announces proposed $200M incremental term loan for acquisitions and growth","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Seeks $200 million incremental term loan under existing credit agreement, maturing April 18, 2031.","Proceeds to finance future acquisitions, organic expansion, health system partnerships, and general corporate purposes.","CFO Mark Stolper expects consummation towards mid-June 2026, subject to customary market conditions.","Loan will be added to existing term loan under the same Third Amended and Restated First Lien Credit Agreement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":4233666943.59793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":98866,"accession_number":"0001683168-26-003624","cik":790526,"company_name":"RadNet, Inc.","ticker":"RDNT","form_type":"8-K","filed_at":"2026-05-11T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"RadNet Q1 revenue $575.6M (+22.1%), adj. EBITDA $63.3M (+36.3%); raises FY guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total Revenue $575.6M, up 22.1% YoY; Adjusted EBITDA $63.3M, up 36.3% YoY.","Digital Health revenue $29.1M (+51.5% YoY); ARR $96.9M vs $49.8M prior year.","Advanced imaging volumes: aggregate +19.7%, same-center +8.2% vs Q1 2025.","GAAP net loss $33.5M ($0.43/share) vs $37.9M ($0.51) prior year; adjusted loss per share $(0.28) vs $(0.34).","Revised FY 2026 Imaging Center guidance: Revenue $2,355M-$2,405M, Adj. EBITDA $340-$353M, FCF $112-$122M."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.43,"consensus_revenue_estimate":null,"consensus_revenue_actual":575631000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":4233666943.59793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":114570,"accession_number":"0001683168-26-001385","cik":790526,"company_name":"RadNet, Inc.","ticker":"RDNT","form_type":"8-K","filed_at":"2026-03-02T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"RadNet Q4 revenue $547.7M record; Adj. EBITDA $87.7M record; issues 17-22% growth guide for 2026","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 2025 revenue $547.7M (+14.8% YoY); Adj. EBITDA $87.7M (+16.9% YoY) - both quarterly records.","GAAP net loss $(0.6)M ($(0.01)/share) vs net income $5.3M ($0.07) in Q4 2024; adjusted EPS $0.23 vs $0.24.","Digital Health Q4 revenue $27.9M (+48.2%); full-year ARR $75.4M, 81% of revenue.","FY2026 guidance: Imaging Center rev $2,325-$2,375M (+17-19%), Adj. EBITDA $335-$348M (+18-22%).","Acquired AI firm Gleamer (Paris) on Mar 2, 2026; adds ~$16M revenue, ~$5M Adj. EBITDA drag to 2026 guide."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":4233666943.59793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":114569,"accession_number":"0001683168-26-001384","cik":790526,"company_name":"RadNet, Inc.","ticker":"RDNT","form_type":"8-K","filed_at":"2026-03-02T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"RadNet acquires Gleamer for up to €230M; DeepHealth becomes largest radiology AI provider","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["All-cash deal includes ~€215M closing payment and up to €15M milestone-based contingent payment.","Gleamer serves >700 customer contracts in 44 countries with FDA-cleared and CE-marked AI solutions.","Gleamer ARR grew >90% CAGR 2022-2025; expected ~$30M ARR in 2026.","Combined portfolio covers MR, CT, X-ray, Mammography, and Ultrasound with 25+ clinical indications.","RadNet expects to deploy Gleamer's solutions for productivity gains in its imaging network by Q3 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":4233666943.59793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":114568,"accession_number":"0001683168-26-000636","cik":790526,"company_name":"RadNet, Inc.","ticker":"RDNT","form_type":"8-K","filed_at":"2026-01-30T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"RadNet registers 190,924 shares for resale by Cimar Sellers as acquisition consideration","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Registration covers up to 190,924 shares of common stock for resale by Cimar Sellers.","Shares are non-cash portion of consideration for acquisition of Cimar (UK) Limited on November 10, 2025.","Prospectus supplement filed under shelf registration Statement No. 333-291945.","Legal opinion from Reed Smith LLP attached as Exhibit 5.1."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":4233666943.59793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":114567,"accession_number":"0001683168-26-000190","cik":790526,"company_name":"RadNet, Inc.","ticker":"RDNT","form_type":"8-K","filed_at":"2026-01-09T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"RadNet promotes four senior leaders to expanded executive roles; sets new salaries","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Stephen Forthuber promoted to President and CEO, Eastern Operations; annual base salary $950,000.","Norman Hames promoted to President and CEO, Western Operations; annual base salary $950,000.","Mital Patel promoted to Executive Vice President and COO; annual base salary $925,000.","Dr. Greg Sorensen named Chief Strategy Officer (from Chief Science Officer); remains on Board.","Executive salary adjustments effective Jan 1, 2026: Stolper $850k, Wesdorp $850k."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":4233666943.59793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":130939,"accession_number":"0001683168-25-008900","cik":790526,"company_name":"RadNet, Inc.","ticker":"RDNT","form_type":"8-K","filed_at":"2025-12-04T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"RadNet files shelf registration and resale prospectus for 73,567 shares","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Filed Form S-3 shelf registration statement (File No. 333-291945) to maintain an effective shelf.","Prospectus supplement registers up to 73,567 shares of common stock for resale by selling stockholders.","Resale Prospectus Supplement supersedes prior shelf registration statement and accompanying prospectus.","Filed opinion of counsel Reed Smith LLP regarding legality of the registered securities."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":4233666943.59793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":130938,"accession_number":"0001683168-25-008100","cik":790526,"company_name":"RadNet, Inc.","ticker":"RDNT","form_type":"8-K","filed_at":"2025-11-10T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"RadNet Q3 revenue $522.9M (+13.4% YoY), adj. EBITDA $84.9M (+15.2%), raises FY2025 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total revenue $522.9M vs $461.1M a year ago; adjusted EPS $0.20 (up from $0.18).","Aggregate advanced imaging volumes +13.0%; same-center advanced imaging volumes +9.9%.","Imaging Center revenue guidance raised to $1.90-$1.93B; adj. EBITDA to $276-$284M.","Digital Health revenue $24.8M (+51.6%), including iCAD contribution from mid-July.","Cash balance $804.7M; net debt / adj. EBITDA ratio ~1.0x."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.24,"consensus_revenue_estimate":null,"consensus_revenue_actual":1492498000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":4233666943.59793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":130937,"accession_number":"0001683168-25-007694","cik":790526,"company_name":"RadNet, Inc.","ticker":"RDNT","form_type":"8-K","filed_at":"2025-10-21T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"RadNet files prospectus supplement to register 59,444 shares for resale by selling stockholders","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Prospectus supplement filed on October 21, 2025, to register up to 59,444 shares of common stock for resale.","Selling stockholders referenced in the supplement may offer shares from time to time.","Registration does not involve new issuance by RadNet; no dilution beyond existing shares.","Legal opinion from Reed Smith LLP on the legality of the registered securities filed as Exhibit 5.1."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":4233666943.59793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":147515,"accession_number":"0001683168-25-005844","cik":790526,"company_name":"RadNet, Inc.","ticker":"RDNT","form_type":"8-K","filed_at":"2025-08-11T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"RadNet Q2 revenue $498.2M (+8.4% YoY), record Adj. EBITDA $81.2M; raises FY2025 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 revenue $498.2M (+8.4% YoY), Adjusted EBITDA $81.2M (record, +12.3%), margin up 57bps to 16.3%.","Adjusted EPS $0.31 vs $0.16 YoY; net income $14.5M vs net loss of $3.0M last year.","Digital Health revenue $20.7M (+30.9% YoY); same-center advanced imaging volumes: MRI +6.6%, PET/CT +16.2%.","Raised 2025 guidance: Imaging Center Net Revenue to $1.85-1.9B, Adjusted EBITDA $271-279M.","Balance sheet: cash $833.2M, net debt/EBITDA 0.96x; one de novo center opened, nine more planned."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.32,"consensus_revenue_estimate":null,"consensus_revenue_actual":969629000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":4233666943.59793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":147514,"accession_number":"0001683168-25-005180","cik":790526,"company_name":"RadNet, Inc.","ticker":"RDNT","form_type":"8-K","filed_at":"2025-07-17T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"RadNet completes iCAD acquisition via DeepHealth subsidiary; expands AI breast health","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["DeepHealth, RadNet's digital health segment, closed acquisition of iCAD (NASDAQ: ICAD).","iCAD's AI portfolio includes breast cancer detection, risk evaluation, and density assessment in 50+ countries.","Combined installed base of 1,500+ healthcare provider locations, covering over 10 million mammograms annually.","Acquisition positions DeepHealth with industry-leading AI-powered breast cancer screening and workflow solutions.","iCAD will operate as a wholly-owned subsidiary of RadNet, integrated into DeepHealth."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":4233666943.59793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":166168,"accession_number":"0001683168-25-004440","cik":790526,"company_name":"RadNet, Inc.","ticker":"RDNT","form_type":"8-K","filed_at":"2025-06-12T23:59:59+00:00","items":["1.01","2.03","5.07","7.01","9.01"],"status":"ready","headline":"RadNet secures $100M incremental term loan for acquisitions; shareholder votes routine","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Incremental term loan of $100M from Barclays; matures April 18, 2031, same as existing $868.4M loan.","Quarterly principal payments increase to ~$2.4M from ~$2.2M; all other credit terms unchanged.","Proceeds to finance acquisitions and general corporate purposes; RadNet had $717M cash at March 31, 2025.","At June 10 annual meeting, stockholders elected 7 directors, ratified EY as auditor (67.8M for), and approved say-on-pay (50.8M for).","No changes to existing covenants or security provisions under the credit agreement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":4233666943.59793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":166167,"accession_number":"0001683168-25-003385","cik":790526,"company_name":"RadNet, Inc.","ticker":"RDNT","form_type":"8-K","filed_at":"2025-05-12T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"RadNet Q1 revenue up 9.2% to $471M, net loss $37.9M; raises 2025 revenue and EBITDA guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $471.4M (+9.2% YoY); Adjusted EBITDA $46.4M (-20.6% YoY) hit by $22M revenue and $15M EBITDA from SoCal wildfires and winter weather.","Net loss $37.9M ($0.51 diluted loss) vs $2.8M loss YoY; adjusted diluted loss per share $(0.35).","Digital Health revenue up 31.1% to $19.2M; Adjusted EBITDA up 5.4% to $3.7M.","Raises 2025 imaging center guidance: revenue $1,835-1,885M (from $1,825-1,875M), Adj. EBITDA $268-276M (from $265-273M).","On April 15, 2025, signed definitive agreement to acquire iCAD, Inc. to accelerate AI-powered breast cancer detection."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.51,"consensus_revenue_estimate":null,"consensus_revenue_actual":471399000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":4233666943.59793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":166166,"accession_number":"0001683168-25-002591","cik":790526,"company_name":"RadNet, Inc.","ticker":"RDNT","form_type":"8-K","filed_at":"2025-04-15T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"RadNet to acquire iCAD for ~$103M all-stock; ~98% premium","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["All-stock acquisition of iCAD for ~$103M (0.0677 RDNT shares per ICAD share); ~98% premium to ICAD's April 14 close.","Expected close in Q2 or Q3 2025, subject to iCAD stockholder approval and customary conditions.","Combines RadNet's DeepHealth with iCAD's ProFound Breast Health Suite; iCAD has 1,500+ provider locations across 50+ countries.","RadNet will host conference call April 16 at 10:30 AM ET to discuss transaction."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":4233666943.59793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":183659,"accession_number":"0001683168-25-001349","cik":790526,"company_name":"RadNet, Inc.","ticker":"RDNT","form_type":"8-K","filed_at":"2025-03-05T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"RadNet Q4 revenue $477M (+13.5%), Adj EBITDA $75M record; FY2025 guidance issued","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $477.1M (+13.5% y/y), Adjusted EBITDA $75.0M (+14.0%), both quarterly records.","Q4 adjusted EPS $0.22 vs $0.15; aggregate volume +8.0%, same-center volume +4.0%.","Digital Health Q4 revenue $18.9M (+28.1%), Adj EBITDA $4.5M (+61.6%).","Full-year 2024 revenue $1,829.7M (+13.2%), Adj EBITDA $279.5M (+20.3%); net debt/EBITDA <1.0x.","FY2025 Imaging revenue guidance $1,825-$1,875M, Adj EBITDA $265-$273M; Q1 hit by weather/fires (~$22M revenue loss)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":4233666943.59793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":200249,"accession_number":"0001683168-24-008404","cik":790526,"company_name":"RadNet, Inc.","ticker":"RDNT","form_type":"8-K","filed_at":"2024-11-26T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"RadNet amends credit facility, reducing interest rates by 0.25% on $872.8M term loans","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Interest rate on term loans reduced to Term SOFR + 2.25% or base rate + 1.25%.","Revolving credit facility rate reduced by 0.25% subject to pricing grid based on leverage.","Estimated annual cash interest expense reduction of ~$2.2 million.","Call protection provided to lenders for six months following the amendment.","Company reports ~$750M cash and first lien net leverage ratio under 1.0x."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":4233666943.59793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":200248,"accession_number":"0001683168-24-007907","cik":790526,"company_name":"RadNet, Inc.","ticker":"RDNT","form_type":"8-K","filed_at":"2024-11-12T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"RadNet reports record Q3 revenue $461.1M (+14.7%), raises 2024 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $461.1M (+14.7% YoY); Adj. EBITDA $73.7M (+27.2%); adjusted EPS $0.18 vs $0.13.","Digital Health revenue $16.4M (+34.3%), AI revenue $5.1M (+75.8%).","Same-center procedural volumes +5.5%; MRI +9.9%, CT +9.8%, PET/CT +16.8%.","Raised 2024 guidance: Imaging Center revenue $1.71-1.76B, Adj. EBITDA $262-270M, FCF $83-93M.","Cash $748.9M; Net Debt/Adj. EBITDA <1.0x; DeepHealth OS commercial launch Dec 1 at RSNA."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.04,"consensus_revenue_estimate":null,"consensus_revenue_actual":1352563000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":4233666943.59793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":200247,"accession_number":"0001683168-24-007058","cik":790526,"company_name":"RadNet, Inc.","ticker":"RDNT","form_type":"8-K","filed_at":"2024-10-11T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"RadNet Digital Health segment revenue up 34% in H1 2024; AI revenue grows 128% YoY","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Full-year Digital Health revenue guidance of $60-70M with adjusted EBITDA of $13-15M.","H1 2024 Digital Health revenue $30.5M (+34.4% YoY); adjusted EBITDA $6.8M (+381.5%).","AI revenues surged 128% YoY: Breast +202%, Lung +31%, Prostate & Brain +150%.","EBCD program: 21% improvement in cancer detection; 1.5M+ patients evaluated.","DeepHealth OS launched at RSNA Nov 2024; Kees Wesdorp appointed President & CEO of Digital Health."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":4233666943.59793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":216265,"accession_number":"0001683168-24-006338","cik":790526,"company_name":"RadNet, Inc.","ticker":"RDNT","form_type":"8-K","filed_at":"2024-09-12T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"RadNet appoints Kees Wesdorp as President & CEO of Digital Health segment effective Oct 1, 2024","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Wesdorp will lead eRAD, DeepHealth OS and AI solutions under the Digital Health division.","Annual base salary of €636,000; bonuses equal to annual comp for 2026-2027.","Signing bonus of $750,000 paid in RadNet common stock; RSUs for 50,000 shares vesting over 5 years.","Wesdorp previously led Philips’ Precision Diagnosis division and was a managing director at Hellman & Friedman.","Appointment effective October 1, 2024; based in the Netherlands."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":4233666943.59793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":216264,"accession_number":"0001683168-24-005428","cik":790526,"company_name":"RadNet, Inc.","ticker":"RDNT","form_type":"8-K","filed_at":"2024-08-09T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"RadNet Q2 revenue $459.7M (+13.9% YoY), adj. EBITDA $72.3M (+19.7%), raises FY2024 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Adjusted diluted EPS $0.16 vs $0.10 YoY; GAAP net loss $3.0M due to $8.8M debt refinancing costs.","Digital Health revenue $15.8M (+36.4%); AI revenue $5.6M (+136.6%).","Same-center procedural volume +6.1%; MRI +11.7%, CT +9.9%, PET/CT +13.7%.","Imaging Center revenue guidance raised to $1,685-$1,735M; adj. EBITDA to $257-$267M; FCF to $72-$80M.","Completed refinancing adding ~$168M cash; cash balance $741.7M; Net Debt/Adj. EBITDA 1.1x."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.08,"consensus_revenue_estimate":null,"consensus_revenue_actual":891421000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":4233666943.59793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":235818,"accession_number":"0001683168-24-004201","cik":790526,"company_name":"RadNet, Inc.","ticker":"RDNT","form_type":"8-K","filed_at":"2024-06-13T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"RadNet stockholders elect seven directors, ratify auditor, approve say-on-pay at annual meeting","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Quorum of 66,080,565 shares (89.42% of outstanding) represented at the meeting.","All seven director nominees elected; for votes ranged from 42.0M to 56.9M.","Ratification of Ernst & Young as auditor approved: 64.8M for, 1.1M against, 89k abstentions.","Non-binding advisory vote on named executive officer compensation approved: 53.9M for, 6.8M against."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":4233666943.59793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":235817,"accession_number":"0001683168-24-003246","cik":790526,"company_name":"RadNet, Inc.","ticker":"RDNT","form_type":"8-K","filed_at":"2024-05-13T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"RadNet Q1 revenue $431.7M (+10.5% YoY); adjusted EBITDA $58.5M (+21.4%); raises 2024 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q1 net loss $(0.04)/share vs $(0.36) last year; adjusted EPS $0.07 vs $(0.22).","Digital Health revenue $14.7M (+32.3% YoY); AI revenue $4.7M (+118.8%).","FY2024 guidance raised: Imaging Center revenue $1.675-1.725B, Adjusted EBITDA $255-265M.","Aggregate procedural volumes +5.7% YoY; MRI +11.7%, CT +9.1%, PET/CT +17.5%.","Acquired Houston Medical Imaging (Apr 1); cash balance $527M; net debt/EBITDA ~1.0x."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.04,"consensus_revenue_estimate":null,"consensus_revenue_actual":431707000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":4233666943.59793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":235816,"accession_number":"0001683168-24-002513","cik":790526,"company_name":"RadNet, Inc.","ticker":"RDNT","form_type":"8-K","filed_at":"2024-04-18T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"RadNet closes $875M term loan and $282M revolver refinancing, extends maturities","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["New $875M senior secured term loan matures April 2031; revolver of $282M matures April 2029.","Term loan rate: SOFR+2.50% or prime+1.50%; revolver initial rate: SOFR+3.00% or prime+2.00%.","Proceeds refinanced $679M prior term loan (as of Dec 31, 2023) plus accrued interest and fees.","Adds ~$168M cash to balance sheet after paying ~$12.6M accrued interest.","Quarterly term loan principal payments increase to ~$2.2M from ~$1.8M under prior facility."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":4233666943.59793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":235815,"accession_number":"0001683168-24-002291","cik":790526,"company_name":"RadNet, Inc.","ticker":"RDNT","form_type":"8-K","filed_at":"2024-04-11T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"RadNet prices $875M term loan and $282M revolver in upsized refinancing","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["$875M term loan (up from $840M) at SOFR+2.50%, 7-yr maturity; $282M revolver (up from $250M), 5-yr term.","Proceeds to repay existing $679M term loan, fees, and add ~$180M cash to balance sheet for growth and corporate purposes.","CFO Stolper cites reduced borrowing costs, extended maturities, and increased operating flexibility from strong market demand.","Closing expected in April 2024, subject to final documentation and customary closing conditions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":4233666943.59793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":235814,"accession_number":"0001683168-24-002073","cik":790526,"company_name":"RadNet, Inc.","ticker":"RDNT","form_type":"8-K","filed_at":"2024-04-03T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"RadNet proposes $840M term loan and $250M revolver to refinance existing debt, add $148M for growth","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["RadNet plans $840M term loan (7-yr) and $250M revolver (5-yr), replacing $679M due 2028 and $195M due 2026.","Proceeds to repay existing term loan, pay fees, and add ~$148M cash for growth and general corporate purposes.","CFO Mark Stolper cites strong operating results, successful public offering, and credit rating upgrade as enabling the refinancing.","Refinancing expected to close this month (April 2024), subject to market conditions and lender negotiations."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":4233666943.59793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":253582,"accession_number":"0001683168-24-001430","cik":790526,"company_name":"RadNet, Inc.","ticker":"RDNT","form_type":"8-K","filed_at":"2024-03-12T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"RadNet closes $230.2M common stock offering (5.23M shares at $44.00/share)","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Closed public offering of 5,232,500 shares at $44.00/share, including full exercise of underwriters' option for 682,500 additional shares.","Gross proceeds ~$230.2M; net proceeds ~$218.2M after underwriting discounts and estimated expenses.","Proceeds to be used for general corporate purposes and potential future acquisitions.","Jefferies and Raymond James were joint book-running managers; Truist, Barclays also acted as book-runners."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":4233666943.59793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":253581,"accession_number":"0001683168-24-001310","cik":790526,"company_name":"RadNet, Inc.","ticker":"RDNT","form_type":"8-K","filed_at":"2024-03-05T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"RadNet Q4 revenue record $420.4M (+9.5%), Adj. EBITDA $65.8M (+15%); guides 2024 higher","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $420.4M (+9.5% YoY); Imaging Center revenue $415.3M (+8.6%); total Adj. EBITDA $65.8M (+15%)","Adjusted EPS $0.20 vs $0.11 in Q4 2022; GAAP net loss $1.9M ($0.03 per share)","AI revenue $5.1M (+278% YoY); announces new Digital Health segment combining eRAD informatics with AI","Signed definitive agreement to acquire seven imaging centers in Houston, entering new market","2024 guidance: Imaging Center revenue $1.65-1.7B, Adj. EBITDA $250-260M; Digital Health revenue $60-70M, AI Adj. EBITDA breakeven by YE"],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":4233666943.59793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":253580,"accession_number":"0001683168-24-000099","cik":790526,"company_name":"RadNet, Inc.","ticker":"RDNT","form_type":"8-K","filed_at":"2024-01-05T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"RadNet revises executive base salaries effective Jan 1, 2024; CEO salary set at $3M","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["CEO Howard G. Berger base salary set at $3,000,000.","CFO Mark D. Stolper base salary set at $700,000.","COO Eastern Operations Stephen M. Forthuber base salary set at $800,000.","COO Western Operations Norman R. Hames base salary set at $800,000.","Mital Patel (EVP Financial Planning & Analysis, CAO) base salary set at $750,000."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":4233666943.59793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":271041,"accession_number":"0001683168-23-007874","cik":790526,"company_name":"RadNet, Inc.","ticker":"RDNT","form_type":"8-K","filed_at":"2023-11-13T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"RadNet Q3 revenue up 14.8% to $402M; raises 2023 Adj. EBITDA guidance to $235M-$245M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $402M (+14.8% YoY); Imaging-Center segment revenue $399.1M (+14.3%); procedural volumes +8.6% aggregate, +4.2% same-center.","Imaging-Center Adj. EBITDA $60.4M (+20.3%); overall Adj. EBITDA (incl. AI) $57.9M, up 26.5%.","Diluted GAAP EPS $0.25 vs $0.01; adjusted diluted EPS $0.14 vs $0.09.","AI segment revenue +220.8% YoY and +21.4% sequentially; management targets AI break-even by end of 2024.","Raised 2023 Adj. EBITDA guidance range to $235M-$245M (from $232M-$242M); expanded Cedars-Sinai partnership with new and expanded JVs."],"consensus_eps_estimate":null,"consensus_eps_actual":0.08,"consensus_revenue_estimate":null,"consensus_revenue_actual":1196247000.0,"consensus_period":"2023-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":4233666943.59793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":287923,"accession_number":"0001683168-23-005434","cik":790526,"company_name":"RadNet, Inc.","ticker":"RDNT","form_type":"8-K","filed_at":"2023-08-09T23:59:59+00:00","items":["2.02","5.02","9.01"],"status":"ready","headline":"RadNet reports record Q2 revenue $403.7M, up 13.9% YoY; appoints Dr. Gregory Sorensen as EVP Chief Science Officer","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Imaging Center segment revenue $401.3M (+13.8% YoY); consolidated revenue $403.7M (+13.9%).","Adjusted EBITDA (incl. AI losses) $60.4M (+17.7% YoY); segment adjusted EBITDA $63.7M (+14.7%).","Same-center procedural volume up 7.1%; aggregate volume up 11.4%.","Raised 2023 imaging center revenue guidance to $1.575-1.610B and Adjusted EBITDA to $232-242M; lowered AI guidance.","Appointed Dr. Gregory Sorensen (CEO of DeepHealth) to Board and as EVP Chief Science Officer; effective Aug 8, 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.21,"consensus_revenue_estimate":null,"consensus_revenue_actual":794279000.0,"consensus_period":"2023-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":4233666943.59793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":308273,"accession_number":"0001683168-23-004210","cik":790526,"company_name":"RadNet, Inc.","ticker":"RDNT","form_type":"8-K","filed_at":"2023-06-16T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"RadNet closes upsized public offering of 8.7M shares for ~$259M gross proceeds","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Sold 8,711,250 shares at $29.75 per share, including full overallotment of 1,136,250 shares.","Gross proceeds ~$259.2M; net proceeds ~$245.5M after underwriting discounts and expenses.","Net proceeds used to repay $100M of first lien term loans and for working capital / general corporate purposes.","Jefferies and Raymond James acted as joint active book-running managers; closing occurred June 16, 2023.","Offering was upsized from initial $225M to $259.2M due to strong demand."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":4233666943.59793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":308272,"accession_number":"0001683168-23-003985","cik":790526,"company_name":"RadNet, Inc.","ticker":"RDNT","form_type":"8-K","filed_at":"2023-06-08T23:59:59+00:00","items":["5.02","5.07"],"status":"ready","headline":"RadNet director resigns; shareholders approve equity plan and auditor","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Ruth V. Wilson did not stand for re-election and resigned from board effective June 7, 2023, with no disagreement.","Shareholders elected six directors: Berger, Gordon, Jacobs, Levitt, Spurlock, Swartz.","Ratification of Ernst & Young as auditor for FY2023 approved: 48.7M for, 2.7M against.","Advisory vote on executive compensation approved: 38.6M for, 5.3M against.","Amendment and restatement of Equity Incentive Plan approved: 38.5M for, 5.0M against."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":4233666943.59793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":308271,"accession_number":"0001683168-23-003132","cik":790526,"company_name":"RadNet, Inc.","ticker":"RDNT","form_type":"8-K","filed_at":"2023-05-11T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"RadNet Q1 revenue rises 14% to $391M; raises full-year guidance for revenue and EBITDA","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $390.6M, +14.3% YoY; Imaging Center segment $388.4M, +13.9%.","Adjusted EBITDA (Imaging Centers) $52.7M, +26.2%; total Adj. EBITDA $48.2M, +26.3%.","GAAP net loss $21.0M (($0.36)/share); adjusted loss per share improved to ($0.08) from ($0.13).","Procedural volumes: aggregate +14.0%, same-center +9.3%; MRI +16.7%, CT +16.8%, PET/CT +20.9%.","Revised FY2023 guidance: Imaging revenue $1.55-1.6B, Adj. EBITDA $225-235M; cash interest, capex ranges up."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.36,"consensus_revenue_estimate":null,"consensus_revenue_actual":390564000.0,"consensus_period":"2023-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":4233666943.59793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":308270,"accession_number":"0001683168-23-002619","cik":790526,"company_name":"RadNet, Inc.","ticker":"RDNT","form_type":"8-K","filed_at":"2023-04-26T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"RadNet enters new CEO employment agreement with Dr. Howard Berger; base salary $1.5M, enhanced severance","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Annual base salary of $1.5M, of which $500k is paid by BRMG; eligible for bonus and incentive plans (bonus paid by BRMG).","Time-based equity awards fully vest upon a change in control of RadNet.","Severance on qualifying termination: up to 200% base salary plus 200% average cash bonus, reduced by $2.5M Berger Termination Payment.","COBRA premium and life insurance continued for up to 2 years after qualifying termination.","Agreement replaces prior 1992 employment agreement; Management Consulting Agreement with BRMG remains unchanged."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":4233666943.59793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":308269,"accession_number":"0001683168-23-002122","cik":790526,"company_name":"RadNet, Inc.","ticker":"RDNT","form_type":"8-K","filed_at":"2023-04-04T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"RadNet amends credit agreement to replace LIBOR with SOFR; credit spread adjustments up to 0.42826%","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Amendment replaces LIBOR with SOFR as interest rate benchmark for first-lien credit facility.","Credit spread adjustments: 0.11448% (1-month), 0.26161% (3-month), 0.42826% (6-month).","Effective March 31, 2023; all other material terms of credit agreement unchanged.","Borrower: RadNet Management, Inc.; guarantors include RadNet, Inc. and subsidiaries; Barclays Bank PLC as administrative agent.","Amendment entered into on March 27, 2023 and disclosed as a material definitive agreement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":4233666943.59793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":327129,"accession_number":"0001683168-23-001214","cik":790526,"company_name":"RadNet, Inc.","ticker":"RDNT","form_type":"8-K","filed_at":"2023-03-01T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"RadNet Q4 revenue $383.9M (+15.2% YoY); 2023 guidance projects 7-10% revenue growth","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Imaging Center segment revenue $382.5M (+15.1% YoY); Adjusted EBITDA $61.6M (+18.4% YoY).","Q4 net loss $934k ($0.02 loss per share); adjusted EPS $0.11 vs $0.10 YoY.","Aggregate procedural volumes +8.0%; same-center volumes +3.6% vs Q4 2021.","2023 guidance: Imaging Center revenue $1.525-1.575B, Adjusted EBITDA $220-230M.","AI segment revenue expected $16-18M in 2023; AI segment projected profitable in 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":0.17,"consensus_revenue_estimate":null,"consensus_revenue_actual":1430061000.0,"consensus_period":"2022-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":4233666943.59793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":344863,"accession_number":"0001683168-22-007504","cik":790526,"company_name":"RadNet, Inc.","ticker":"RDNT","form_type":"8-K/A","filed_at":"2022-11-10T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"RadNet files 8-K/A to furnish Q3 2022 earnings call transcript; no specific financial data in provided excerpt","summary_kind":"llm","event_type":"earnings","confidence":"low","bullets":["Filing amends prior 8-K; adds transcript of November 9, 2022 conference call as Exhibit 99.1.","Transcript excerpt includes introductory remarks only; no quarterly results or guidance figures are visible in furnished text.","Original 8-K reported Q3 2022 results; this amendment does not contain new financial disclosures.","Company hosted call with CFO Mark Stolper and CEO Dr. Howard Berger."],"consensus_eps_estimate":null,"consensus_eps_actual":0.19,"consensus_revenue_estimate":null,"consensus_revenue_actual":1046185000.0,"consensus_period":"2022-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":4233666943.59793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":344864,"accession_number":"0001683168-22-007458","cik":790526,"company_name":"RadNet, Inc.","ticker":"RDNT","form_type":"8-K","filed_at":"2022-11-09T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"RadNet Q3 revenue up 5.2% to $350M; Adj EBITDA down 8.5%; guides FY 2022 lower","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Imaging Centers Adj EBITDA $50.2M vs $54.9M YoY, down 8.5% on labor costs/shortage.","Diluted EPS $0.01; adjusted EPS $0.09 vs $0.21 YoY.","FY 2022 Adj EBITDA guidance cut to $203-208M (from $208-218M); free cash flow $60-70M.","Acquired Heart&Lung Health (UK teleradiology) and Montclair Radiology (6 NJ centers).","Launched Enhanced Breast Cancer Detection pilot with DeepHealth AI in Delaware."],"consensus_eps_estimate":null,"consensus_eps_actual":0.19,"consensus_revenue_estimate":null,"consensus_revenue_actual":1046185000.0,"consensus_period":"2022-Q3","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":4233666943.59793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":361330,"accession_number":"0001683168-22-006170","cik":790526,"company_name":"RadNet, Inc.","ticker":"RDNT","form_type":"8-K","filed_at":"2022-09-02T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"RadNet enters new employment agreements with four top executives","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["New agreements effective Sept 1, 2022 for CFO Stolper ($575k), COO Eastern Forthuber ($650k), COO Western Hames ($650k), EVP/CAO Patel ($575k).","All four have >10 years service; severance pay = 2x base salary + 2x average cash bonus; Hames gets additional $1.05M lump sum.","Time-based equity fully vests upon change in control or qualifying termination; COBRA benefits continued for 2 years.","Agreements are at-will with uniform terms; replace prior individual contracts."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":4233666943.59793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":361328,"accession_number":"0001683168-22-005616","cik":790526,"company_name":"RadNet, Inc.","ticker":"RDNT","form_type":"8-K/A","filed_at":"2022-08-12T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"RadNet files 8-K/A furnishing Q2 2022 earnings call transcript; no new financial details","summary_kind":"llm","event_type":"earnings","confidence":"low","bullets":["Original Q2 2022 earnings results were reported on August 9, 2022.","This 8-K/A adds the transcript of the August 9 conference call as Exhibit 99.1.","No specific financial figures or guidance changes are available in the partial exhibit provided.","The filing is procedural and does not contain material new information beyond the original results."],"consensus_eps_estimate":null,"consensus_eps_actual":0.18,"consensus_revenue_estimate":null,"consensus_revenue_actual":696141000.0,"consensus_period":"2022-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":4233666943.59793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":361329,"accession_number":"0001683168-22-005523","cik":790526,"company_name":"RadNet, Inc.","ticker":"RDNT","form_type":"8-K","filed_at":"2022-08-10T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"RadNet Q2 2022 revenue up 6.1% to $354.4M; reaffirms full-year guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $354.4M (+6.1% YoY); Imaging Centers revenue $352.8M (+5.7%).","Imaging Centers Adj. EBITDA $55.5M, down 3.2% YoY; overall Adj. EBITDA $51.3M vs $56.6M.","Diluted EPS $0.13 (vs $0.05); adjusted diluted EPS $0.15 from $8.6M adjusted earnings.","Procedural volumes: aggregate +4.5%, same-center +2.2%; MRI/CT/PET volumes up 8%/7%/10%.","Reaffirms FY 2022 guidance except capex raised to $90-95M; cash $99.2M, $195M credit line."],"consensus_eps_estimate":null,"consensus_eps_actual":0.18,"consensus_revenue_estimate":null,"consensus_revenue_actual":696141000.0,"consensus_period":"2022-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":4233666943.59793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":380608,"accession_number":"0001683168-22-004285","cik":790526,"company_name":"RadNet, Inc.","ticker":"RDNT","form_type":"8-K","filed_at":"2022-06-10T23:59:59+00:00","items":["5.07","9.01"],"status":"ready","headline":"RadNet stockholders elect seven directors, ratify auditor, approve say-on-pay at 2022 annual meeting","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All seven director nominees elected: Howard G. Berger, Christine N. Gordon, Laura P. Jacobs, Lawrence L. Levitt, Gregory E. Spurlock, David L. Swartz, Ruth V. Wilson.","Ratification of Ernst & Young as auditor for FY 2022: 48,002,458 for, 1,939,958 against, 20,564 abstain.","Non-binding advisory vote on executive compensation approved: 41,279,176 for, 1,987,913 against, 54,620 abstain, 6,641,271 broker non-votes."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":4233666943.59793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":380607,"accession_number":"0001683168-22-003357","cik":790526,"company_name":"RadNet, Inc.","ticker":"RDNT","form_type":"8-K","filed_at":"2022-05-10T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"RadNet Q1 revenue $341.8M, adj EBITDA $41.7M; raises 2022 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $341.8M (+8.4%); imaging centers $341.2M (+8.2%).","Adj EBITDA from imaging centers $41.7M (+4.1%); diluted EPS $0.05 vs $0.18.","Raised FY2022 guidance: revenue to $1.36B-$1.41B, adj EBITDA to $208M-$218M.","Aggregate procedural volumes +8.8%; same-center +6.6%.","Completed acquisitions of Quantib and Aidence (AI) in Q1; AI revenue $599k, segment loss $3.6M."],"consensus_eps_estimate":null,"consensus_eps_actual":0.05,"consensus_revenue_estimate":null,"consensus_revenue_actual":341767000.0,"consensus_period":"2022-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":4233666943.59793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":398685,"accession_number":"0001683168-22-001373","cik":790526,"company_name":"RadNet, Inc.","ticker":"RDNT","form_type":"8-K","filed_at":"2022-03-02T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"RadNet Q4 revenue $333.2M (+8% YoY), GAAP EPS -$0.07; guides 2022 Adj EBITDA $205-215M ex-AI losses","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $333.2M (+8.0% YoY), Adj EBITDA $54.5M (+7.5%), Adj EPS $0.13 vs $0.20 YoY.","GAAP net loss in Q4 2021 was $3.8M ($0.07 loss per share) vs net income $6.0M ($0.11) in Q4 2020.","Full year 2021 revenue $1,315.1M (+22.7%), Adj EBITDA $218.9M (+57%); Net income $24.7M ($0.46/diluted).","2022 guidance: Revenue $1,350-1,400M, Adj EBITDA (ex-AI losses) $205-215M, CapEx $85-90M, FCF $80-90M.","AI division losses expected $12-17M in 2022; completed acquisitions of Aidence and Quantib (Netherlands AI cos)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":4233666943.59793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":398684,"accession_number":"0001683168-22-000553","cik":790526,"company_name":"RadNet, Inc.","ticker":"RDNT","form_type":"8-K","filed_at":"2022-01-28T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"RadNet acquires Aidence and Quantib, outlines AI strategy for cancer screening and operations","summary_kind":"llm","event_type":"m_and_a","confidence":"medium","bullets":["Acquired Aidence (AI for lung cancer screening) and Quantib (AI for prostate MRI) to bolster AI portfolio.","Conference call highlighted AI opportunities in clinical enhancements, business ops, and revenue growth.","Dr. Greg Sorensen, CEO of DeepHealth, leads RadNet's AI division.","Financial terms of the acquisitions were not disclosed in the filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":4233666943.59793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":398683,"accession_number":"0001683168-22-000403","cik":790526,"company_name":"RadNet, Inc.","ticker":"RDNT","form_type":"8-K","filed_at":"2022-01-24T23:59:59+00:00","items":["3.02","9.01"],"status":"ready","headline":"RadNet acquires AI firms Aidence and Quantib for ~$95M combined; issues 2.1M shares","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Aidence acquired for ~$50M (incl. $10M milestones); Quantib for ~$45M.","Issued 1,141,234 shares for Aidence and 965,058 shares for Quantib to stakeholders.","Adds AI for lung nodule (Aidence) and prostate/brain MRI (Quantib) to DeepHealth division.","Quantib products have FDA 510(k) clearance; Aidence's Veye pending FDA approval.","Dr. Gregory Sorensen to lead combined AI initiatives across all three entities."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":4233666943.59793,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":"2022-01-24T23:59:59+00:00|398683"}